6 Needs context
In early 2024, human brain samples were found to contain on average 0.5% plastic by weight.
"In early 2024, human brain samples were found to have on average 0.5% plastic by weight." (said at 0:00:15)
The claim accurately reports the findings of a widely publicized study released in May 2024 (a preprint by Nihart et al., University of New Mexico), which analyzed decedent frontal cortex samples using pyrolysis gas chromatography-mass spectrometry and reported mean plastic concentrations of 4,883 µg/g (approximately 0.49% to 0.5% by weight). However, this figure originates from preliminary preprint data that has not undergone peer review, and measuring plastic mass fractions in human tissue via pyrolysis-GC/MS remains experimental. In peer-reviewed postmortem human brain research (e.g., Amato-Lourenço et al., JAMA Network Open 2024), microplastics have been confirmed in human olfactory bulb tissue, but as discrete micro-scale particles (16 particles/fibers across 8 of 15 individuals) rather than substantial percentages of organ mass.
In women, higher phthalate exposure is associated with irregular menstrual cycles and an increased risk of endometriosis.
"In women, exposure to higher phthalate levels is associated with irregular menstrual cycles and a higher risk of endometriosis, which is a painful condition that can lead to fertility issues." (said at 0:25:49)
The claim is partially supported by meta-analyses showing associations between certain specific phthalate metabolites and increased risk of endometriosis, but overstated or unverified regarding irregular menstrual cycles. Meta-analyses of epidemiological data (e.g., Wang et al., 2019; PMIDs 31574938, 38640992) confirm that exposure to specific DEHP metabolites, such as mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) and mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), is significantly associated with an elevated risk of endometriosis in women. However, studies examining phthalate concentrations and menstrual cycle characteristics (e.g., PMID 38064925) found generally null associations between urinary/follicular phthalate metabolites and irregular cycles or cycle length variation, though inverse associations with bleeding duration and cycle length were noted for specific metabolites.
- supports: Association between Phthalate Metabolites and Risk of Endometriosis: A Meta-Analysis. (International journal of environmental research and public health 2019) · cited 55x in the literature
"The results of this analysis showed that mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) exposure was potentially associated with endometriosis (OR = 1.246, 95% CI = 1.003-1.549)." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Phthalate metabolites in urine and follicular fluid in relation to menstrual cycle charact… (Environment international 2024) · cited 13x in the literature
"However, we generally observed null associations between phthalate metabolites and irregular cycle, dysmenorrhea, hypomenorrhea, or cycle length variation." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Plastic-related endocrine disrupting chemicals significantly related to the increased risk… (Environmental research 2024) · cited 28x in the literature
"Phthalate metabolites and endometriosis risk; MBP ES 1.07 (95% CI; 0.86, 1.33), MEP ES 1.05 (95% CI; 0.87, 1.28), MEHP ES 1.15 (95% CI; 0.67, 1.98), MBzP ES 0.97 (95% CI; 0.63, 1.49), MEOHP ES 1.87 (95% CI; 1.21, 2.87), and MEHHP ES 1.98 (95% CI; 1.32, 2.98)." (abstract, results, passage verified)
pubmedfull study (doi)
Adults and adolescents with higher urinary BPA levels have lower testosterone levels and altered estrogen metabolism.
"For instance, one study found that adults and adolescents with higher urinary BPA levels had lower testosterone levels and altered estrogen metabolism." (said at 0:18:28)
Cross-sectional analyses of population surveys (such as the U.S. National Health and Nutrition Examination Survey, NHANES) have reported associations between higher urinary bisphenol A (BPA) concentrations and altered sex steroid hormone levels. However, these findings require context: the inverse association with testosterone is sex-specific (observed in adolescent boys and as lower free testosterone in adult men, while adolescent girls showed positive associations with total testosterone). Furthermore, studies examining estrogen levels observed lower estradiol in adolescents but no consistent associations in adults. Because these findings are from cross-sectional observational surveys, they reflect statistical associations rather than proven causal effects or uniform endocrine changes across all demographic groups.
- context: Serum Testosterone Concentrations and Urinary Bisphenol A, Benzophenone-3, Triclosan, and … (Environmental health perspectives 2016) · cited 148x in the literature
"BP-3 and BPA were associated with significantly lower TT in male adolescents, and BPA was associated with significantly higher TT in female adolescents." (abstract, results, passage verified)
pubmedfull study (doi) - context: Associations among urinary triclosan and bisphenol A concentrations and serum sex steroid … (Environment international 2021) · cited 50x in the literature
"Increasing BPA was associated with lower levels of E2 in 6-11-year-old boys and in adolescents aged 12-19 years of either sex. We observed a U-shaped association between urinary triclosan and E2 in male adults aged 50-79 years; no associations between BPA and hormones were detected in adults." (abstract, results, passage verified)
pubmedfull study (doi) - context: Associations between urinary concentrations of bisphenols and serum concentrations of sex … (Environmental health : a global access science source 2022) · cited 14x in the literature
"However, there was no significant association between BPA or BPS and TT. Furthermore, increased BPA and BPS levels were associated with higher levels of sex hormone-binding globulin (SHBG)... Both BPA and BPS were negatively associated with free testosterone (FT, nmol/L) after full adjustment" (abstract, results)
pubmedfull study (doi)
BPA is cleared and excreted by the human body within approximately 6 hours under normal conditions.
"For example, BPA is cleared relatively fast, within about 6 hours under normal conditions." (said at 1:04:58)
Human pharmacokinetic studies using orally administered isotope-labeled bisphenol A (d6-BPA) demonstrate that BPA has a terminal elimination half-life of approximately 6 hours (6.2–6.4 hours) in blood. Because 6 hours represents the half-life rather than total clearance, roughly 50% of the compound is eliminated in that timeframe, while substantial urinary excretion (>90%) takes approximately 24 hours. In contrast, dermal exposure results in a much longer elimination half-life (~18–21 hours).
Rodents exposed to BPA and treated with sulforaphane exhibit increased Phase 2 detoxification enzyme activity and reduced BPA-related toxicity.
"Animal studies have shown that when rodents are exposed to BPA and given sulforaphane, their Phase 2 detoxification enzymes go into overdrive and they experience less overall BPA-related toxicity." (said at 1:07:02)
Animal studies demonstrate that sulforaphane treatment reduces overall BPA-induced toxicity in rodents (e.g., mitigating BPA-induced hepatic lipid accumulation, ER stress, and obesity). Additionally, sulforaphane is well-established to induce Phase 2 detoxification enzymes (such as GST and NRF2-mediated target enzymes) in rodent models. However, the specific rodent studies directly evaluating sulforaphane's protective effects against BPA toxicity documented mechanisms such as inhibition of endoplasmic reticulum (ER) stress and activation of AMPK pathways rather than measuring or attributing the protective effect specifically to Phase 2 detoxification enzyme induction in the co-exposed animals.
A study published in the Journal of Environmental and Public Health found measurable levels of phthalates in human sweat.
"One study published in the Journal of Environmental and Public Health found measurable levels of phthalates in sweat of participants." (said at 1:10:52)
A study assessing phthalate excretion in sweat, blood, and urine—part of the Blood, Urine, and Sweat (BUS) study by Genuis et al.—did find measurable levels of parent phthalates and phthalate metabolites (such as MEHP and DEHP) in human sweat across 20 participants. However, the phthalate study was published in TheScientificWorldJournal in 2012, whereas companion papers from the same research group examining bisphenol A and toxic metals were published in the Journal of Environmental and Public Health. The study was an observational pilot study with a small sample size (n = 20).
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.